Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Price, Quote, News and Overview

NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD

40.46  -0.57 (-1.39%)

After market: 40.46 0 (0%)

QDEL Quote, Performance and Key Statistics

QUIDELORTHO CORP

NASDAQ:QDEL (2/21/2025, 8:00:01 PM)

After market: 40.46 0 (0%)

40.46

-0.57 (-1.39%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High49.45
52 Week Low29.74
Market Cap2.72B
Shares67.26M
Float66.26M
Yearly Dividend0
Dividend YieldN/A
PE21.87
Fwd PE16.57
Earnings (Next)N/A N/A
IPO02-01 1991-02-01


QDEL short term performance overview.The bars show the price performance of QDEL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6 -8 -10

QDEL long term performance overview.The bars show the price performance of QDEL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of QDEL is 40.46 USD. In the past month the price decreased by -8.73%. In the past year, price decreased by -13.71%.

QUIDELORTHO CORP / QDEL Daily stock chart

QDEL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About QDEL

Company Profile

QDEL logo image QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 7,100 full-time employees. The firm sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The firm provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. The company provides support for its customers across more than 130 countries and territories.

Company Info

QUIDELORTHO CORP

9975 Summers Ridge Road

San Diego CALIFORNIA 92121 US

CEO: Douglas C. Bryant

Employees: 7100

Company Website: https://www.quidelortho.com/

Investor Relations: https://ir.quidel.com/

Phone: 18585521100

QUIDELORTHO CORP / QDEL FAQ

What is the stock price of QUIDELORTHO CORP today?

The current stock price of QDEL is 40.46 USD. The price decreased by -1.39% in the last trading session.


What is the ticker symbol for QUIDELORTHO CORP stock?

The exchange symbol of QUIDELORTHO CORP is QDEL and it is listed on the Nasdaq exchange.


On which exchange is QDEL stock listed?

QDEL stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for QUIDELORTHO CORP stock?

15 analysts have analysed QDEL and the average price target is 54.5 USD. This implies a price increase of 34.69% is expected in the next year compared to the current price of 40.46. Check the QUIDELORTHO CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is QUIDELORTHO CORP worth?

QUIDELORTHO CORP (QDEL) has a market capitalization of 2.72B USD. This makes QDEL a Mid Cap stock.


How many employees does QUIDELORTHO CORP have?

QUIDELORTHO CORP (QDEL) currently has 7100 employees.


What are the support and resistance levels for QUIDELORTHO CORP (QDEL) stock?

QUIDELORTHO CORP (QDEL) has a support level at 40.27 and a resistance level at 40.55. Check the full technical report for a detailed analysis of QDEL support and resistance levels.


Is QUIDELORTHO CORP (QDEL) expected to grow?

The Revenue of QUIDELORTHO CORP (QDEL) is expected to grow by 0.53% in the next year. Check the estimates tab for more information on the QDEL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy QUIDELORTHO CORP (QDEL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does QUIDELORTHO CORP (QDEL) stock pay dividends?

QDEL does not pay a dividend.


What is the Price/Earnings (PE) ratio of QUIDELORTHO CORP (QDEL)?

The PE ratio for QUIDELORTHO CORP (QDEL) is 21.87. This is based on the reported non-GAAP earnings per share of 1.85 and the current share price of 40.46 USD. Check the full fundamental report for a full analysis of the valuation metrics for QDEL.


What is the Short Interest ratio of QUIDELORTHO CORP (QDEL) stock?

The outstanding short interest for QUIDELORTHO CORP (QDEL) is 5.15% of its float. Check the ownership tab for more information on the QDEL short interest.


QDEL Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to QDEL. When comparing the yearly performance of all stocks, QDEL is a bad performer in the overall market: 72.81% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

QDEL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to QDEL. Both the profitability and financial health of QDEL have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QDEL Financial Highlights

Over the last trailing twelve months QDEL reported a non-GAAP Earnings per Share(EPS) of 1.85. The EPS decreased by -55.21% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -27.45%
ROE -58.57%
Debt/Equity 0.68
Chartmill High Growth Momentum
EPS Q2Q%-46.15%
Sales Q2Q%-4.69%
EPS 1Y (TTM)-55.21%
Revenue 1Y (TTM)-7.17%

QDEL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to QDEL. The Buy consensus is the average rating of analysts ratings from 15 analysts.

For the next year, analysts expect an EPS growth of 31.99% and a revenue growth 0.53% for QDEL


Ownership
Inst Owners109.74%
Ins Owners0.49%
Short Float %5.15%
Short Ratio3.71
Analysts
Analysts76
Price Target54.5 (34.7%)
EPS Next Y31.99%
Revenue Next Year0.53%